This acquisition will add asthma treatment A1O-001 to GSK’s portfolio.
GSK Completes Acquisition of Aiolos Bio
Estimated read time
1 min read
This acquisition will add asthma treatment A1O-001 to GSK’s portfolio.
+ There are no comments
Add yours